Metraipolis › archive › dc_1028b48cbeaa
Blinatumomab combined with low-dose chemotherapy and tyrosine kinase inhibitors as first-line induction for newly diagnosed Philadelphia chromosome-positive… — Europe PMC PMID:41393154
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41393154
- DOI
- 10.3389/fmed.2025.1687242
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T04:39:22.744Z
- SHA-256 of the archived text
795782602d582bf9c5ca9559699676d803aeceee1a2bf0da48b022940a0e87c3- Stable URL of this page
https://metraipolis.com/documento/dc_1028b48cbeaa
How to cite
Blinatumomab combined with low-dose chemotherapy and tyrosine kinase inhibitors as first-line induction for newly diagnosed Philadelphia chromosome-positive… — Europe PMC PMID:41393154 — Europe PMC (en), https://europepmc.org/article/MED/41393154 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1028b48cbeaa (Metraipolis archive dc_1028b48cbeaa, sha256 795782602d582bf9c5ca9559699676d803aeceee1a2bf0da48b022940a0e87c3)
BibTeX
@misc{dc1028b48cbeaa,
title = {Blinatumomab combined with low-dose chemotherapy and tyrosine kinase inhibitors as first-line induction for newly diagnosed Philadelphia chromosome-positive… — Europe PMC PMID:41393154},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41393154},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1028b48cbeaa; sha256 795782602d582bf9c5ca9559699676d803aeceee1a2bf0da48b022940a0e87c3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41393154. Agents can read the archived copy with the MCP tool read_document.